Ask AI

A Call to Action to the Community: Overcoming Obstacles in the Optimal Treatment of TNBC with TROP-2 Directed Therapy

Optimize your care for patients with triple-negative breast cancer (TNBC) by discovering the latest updates and best clinical practices for TROP-2 targeted therapies through an expert Think Tank, certified online text modules, downloadable slidesets, and a ClinicalThought commentary.

Share

Program Content

Activities

Rationale for TROP2 ADCs in TNBC
Foundations of ADC Therapy and the Clinical Rationale for Targeting TROP-2 in TNBC
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2026

Expires: January 09, 2027

Activities

Rationale for TROP2 ADCs in TNBC
TROP-2–Directed ADCs in TNBC: Foundations and Rationale
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: July 10, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.

Supporters

Supported by an educational grant from Gilead Sciences, Inc.

Gilead Sciences, Inc.